Physiological Approaches to Increase Biocompatibility of Peritoneal Dialysis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Peritoneal Dialysis International

• Publication date

  1995-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/089686089501507S11PMID 8555331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release

  2005cited by this paper
• Intraperitoneal Inflammation after Previous Contact with Killed Microbes

  1995cited by this paper
• Eosinophilic Peritonitis and Drug-Induced Lymphocyte Transformation in Vitro

  1995cited by this paper
• Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients.

  1995cited by this paper
• Changes in Biocompatibility of Dialysis Fluid during Its Dwell in the Peritoneal Cavity

  1995cited by this paper
• Protective Effect of Hyaluronic Acid against Peritoneal Injury

  1995cited by this paper
• Physiological Approaches to Increase Biocompatibility of Peritoneal Dialysis

  1995cited by this paper
• Acquired Cystic Disease Mimicking Polycystic Kidney Disease in a Long Term CAPD Patient

  1995cited by this paper
• Pyruvate anions neutralize peritoneal dialysate cytotoxicity.

  1995cited by this paper
• A United Kingdom Multicenter Study of Icodextrin in Continuous Ambulatory Peritoneal Dialysis

  1994cited by this paper
• In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.

  1994cited by this paper
• The Use of Peptides in Peritoneal Dialysis Fluids

  1994cited by this paper
• Biocompatibility Studies on Peritoneal Cells

  1994cited by this paper
• Nutritional requirements of peritoneal dialysis patients

  1994cited by this paper
• Impact of Continuous Ambulatory Peritoneal Dialysis Solutions and Clearance of Macromolecules on Polymorphonuclear Neutrophils

  1994cited by this paper
• In vitro influence of lactate on function of peritoneal fibroblasts.

  1994cited by this paper
• Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.

  1994cited by this paper
• Experimental Approach to Peritoneal Morphology

  1994cited by this paper
• Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats.

  1994cited by this paper
• Icodextrin in Peritoneal Dialysis: Early Development and Clinical Use

  1994cited by this paper
• Ultrastructure and pathology of the peritoneum in peritoneal dialysis

  1994cited by this paper
• N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing.

  1994cited by this paper
• Phosphatidylcholine and Chondroitin Sulphate in Peritoneal Dialysis Fluids to Preserve Membrane Function

  1994cited by this paper
• The source and possible significance of hyaluronan in the peritoneal cavity.

  1994cited by this paper
• Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury.

  1993cited by this paper
• In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.

  1993cited by this paper
• The Cytotoxicity of Continuous Ambulatory Peritoneal Dialysis Solutions with Different Bicarbonate/Lactate Ratios

  1993cited by this paper
• Continuous Ambulatory Peritoneal Dialysis with Bicarbonate Buffer-A Pilot Study

  1993cited by this paper
• In Vitro Study of the Mechanism of Potassium Transport into Human Mesothelial Cells. I: Effect of Hyperosmolality

  1993cited by this paper
• D-lactate metabolism in patients with chronic renal failure undergoing CAPD.

  1993cited by this paper
• Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis.

  1993cited by this paper
• Enhanced Ultrafiltration in Rabbits with Bicarbonate Glycylglycine Peritoneal Dialysis Solution

  1993cited by this paper
• Protection by N-acetylcysteine against pulmonary endothelial cell damage induced by oxidant injury.

  1993cited by this paper
• Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts.

  1993cited by this paper
• Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes.

  1993cited by this paper
• Evaluation of a Peptide-Based Solution for Peritoneal Dialysis

  1993cited by this paper
• Enhancement of viability of human peritoneal mesothelial cells with glutathione precursor: L-2-oxothiazolidine-4-carboxylate.

  1993cited by this paper
• Suppressive Effects of Hyaluronic Acid on Elastase Release from Rat Peritoneal Leucocytes

  1993cited by this paper
• Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.

  1993cited by this paper
• Cell Function and Viability in Glucose Polymer Peritoneal Dialysis Fluids

  1993cited by this paper
• Enhanced rate of H2O2 release from bovine pulmonary artery endothelial cells induced by TGF-beta 1.

  1993cited by this paper
• Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.

  1993cited by this paper
• Lipid Perxidtion and Antioxidants in Continuous Ambulatory Dialysis Patients

  1992cited by this paper
• Toxicity of osmotic solutes on human mesothelial cells in vitro.

  1992cited by this paper
• Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.

  1992cited by this paper
• Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.

  1992cited by this paper
• Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis.

  1992cited by this paper
• Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents.

  1992cited by this paper
• Peritoneal Ultrafiltration after Chronic Exposure to Dialysis Fluid

  1992cited by this paper
• Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats.

  1992cited by this paper
• Hyaluronan.

  1992cited by this paper
• Scarless fetal healing. Therapeutic implications.

  1992cited by this paper
• Neutrophilic Intracellular Acidosis Induced by Conventional, Lactate-Containing Peritoneal Dialysis Solutions

  1992cited by this paper
• Host Defense Mechanisms in the Peritoneal Cavity of Continuous Ambulatory Peritoneal Dialysis Patients: First of Two Parts

  1991cited by this paper
• Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 1.

  1991cited by this paper
• The Mesothelial Cells in CAPD Effluent and Their Relation to Peritonitis Incidence

  1991cited by this paper
• Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat.

  1991cited by this paper
• Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence.

  1991cited by this paper
• Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

  1991cited by this paper
• Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate.

  1991cited by this paper
• Protein glycation and oxidative stress in diabetes mellitus and ageing.

  1991cited by this paper
• Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients.

  1990cited by this paper
• Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells.

  1990cited by this paper
• Stereospecificity of the anti-inflammatory actions of terbutaline.

  1990cited by this paper
• Autologous implant of peritoneal mesothelium in rabbits and man.

  1990cited by this paper
• Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.

  1990cited by this paper
• Interleukin 1-α and tumor necrosis factor-α induce oxygen radical production in mesangial cells

  1990cited by this paper
• Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.

  1990cited by this paper
• Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells.

  1989cited by this paper
• Implant of Autologous Mesothelial Cells in Animals and a Peritoneal Dialysis Patient

  1989cited by this paper
• The Peritoneum and Peritoneal Access.

  1989cited by this paper
• Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patients.

  1989cited by this paper
• Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions.

  1989cited by this paper
• Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis.

  1989cited by this paper
• Loss of Ultrafil Tration in Continuous Ambulatory Peritoneal Dialysis: A Role for Acetate

  1989cited by this paper
• Transforming growth factors (TGFα and TGFβH) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells

  1989cited by this paper
• Hyaluronic acid metabolism in inflamed mesenterium of guinea pig.

  1989cited by this paper
• Peritoneal dialysis in diabetic end-stage renal disease.

  1989cited by this paper
• Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.

  1989cited by this paper
• Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor alpha, tumor necrosis factor beta (lymphotoxin), interleukin-1 alpha, and interleukin-1 beta.

  1988cited by this paper
• Relationships between the cellular glutathione level and in vitro life span of human diploid fibroblasts.

  1988cited by this paper
• Peritoneal Macrophages in Short Dwell Time Effluent Show Diminished Phagocytosis

  1988cited by this paper
• The untoward effects of the anions of dialysis fluids.

  1988cited by this paper
• Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor α, tumor necrosis factor β (lymphotoxin), interleukin-1α, and interleukin-1β

  1988cited by this paper
• L-2-Oxothiazolidine-4-carboxylate protects cultured endothelial cells against hyperoxia-induced injury

  1988cited by this paper
• The medical and metabolic consequences of administration of sodium acetate.

  1988cited by this paper
• Continuous Mesothelial Injury and Regeneration during long Term Peritoneal Dialysis

  1987cited by this paper
• Aspects of new solutions for peritoneal dialysis.

  1987cited by this paper
• The toxic impact of parenteral solutions on the metabolism of cells: a hypothesis for physiological parenteral therapy.

  1986influential reference
• The Accumulation of Pyrophosphate By Rat Hepatocytes

  1986cited by this paper
• A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing.

  1986cited by this paper
• The properties and turnover of hyaluronan.

  1986cited by this paper
• Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice.

  1986cited by this paper
• CAPD, a Permanent State of Peritonitis: A Study on Peroxidase Activity

  1986cited by this paper
• The Morphology of the Peritoneum in CAPD Patients

  1986cited by this paper
• Acute stimulation by glucocorticoids of gluconeogenesis from lactate/pyruvate in isolated hepatocytes from normal and adrenalectomized rats.

  1985cited by this paper
• D-lactate encephalopathy.

  1985cited by this paper
• The interaction between the cytosolic pyridine nucleotide redox potential and gluconeogenesis from lactate/pyruvate in isolated rat hepatocytes. Implications for investigations of hormone action.

  1985cited by this paper
• Acetate versus lactate in peritoneal dialysis solutions.

  1985cited by this paper
• Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.

  1985cited by this paper

• Effects of Bicarbonate/Lactate Dialysis Solution on the Inflammatory Response of Spontaneous Peritonitis in Rats Undergoing Chronic Peritoneal Dialysis

  2009cites this paper
• Mesotheliology: A New Area of Research?

  2007cites this paper
• Peritoneal Transport: From Basics to Bedside

  2003cites this paper
• Relevance of C-reactive protein levels in peritoneal dialysis patients.

  2002cites this paper
• Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells.

  2001cites this paper
• Rat models in peritoneal dialysis.

  2001cites this paper
• Atlas of peritoneal histology.

  2000cites this paper
• Physiological Saline is not a Biocompatible Peritoneal Dialysis Solution

  1999cites this paper
• Does a High Peritoneal Transport Rate Reflect a State of Chronic Inflammation?

  1999cites this paper
• Animal Models for Peritoneal Dialysis

  1999cites this paper
• Experimental models in peritoneal dialysis: a European experience.

  1998cites this paper
• The usefulness of sodium chondroitin sulfate as an osmotic agent for peritoneal dialysis

  1997cites this paper
• Daily exposure to dialysis fluid results in changes in peritoneal transport.

  1997cites this paper
• Making Long-term Peritoneal Dialysis Possible

  1997cites this paper
• Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.

  1997cites this paper
• New strategies for peritoneal dialysis fluids.

  1997cites this paper
• Peritoneal membrane morphology and function.

  1996cites this paper
• In Vitro Studies to Assess Biocompatibility of Peritoneal Dialysis Solutions: Strengths and Limitations

  1996cites this paper
• Physiological Approaches to Increase Biocompatibility of Peritoneal Dialysis

  1995cites this paper